LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy

BACKGROUND: Familial hypercholesterolemia (FH), an autosomal dominant genetic disease with the elevated levels of low‐density lipoprotein (LDL) cholesterol (LDL‐C), increases the risk of coronary artery disease (CAD). The proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamasaki, Masato, Sakane, Naoki, Hara, Kazuo, Kotani, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605117/
https://www.ncbi.nlm.nih.gov/pubmed/34652028
http://dx.doi.org/10.1002/jcla.24056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605117/
https://www.ncbi.nlm.nih.gov/pubmed/34652028
http://dx.doi.org/10.1002/jcla.24056

Ejemplares similares